# BugSigDB 2024-08-14_11:58_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/2/1_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	57037
bsdb:1/6/1_Colorectal-adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	57037
bsdb:5/1/2_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1470358
bsdb:6/1/1_Non-alcoholic-fatty-liver-disease:advanced-fibrosis_vs_mild/moderate-fibrosis_DOWN	NA	40520	39491
bsdb:7/1/1_Autism:severely-autistic_vs_non-sibling-control_UP	NA	901	876	58621	821
bsdb:7/1/2_Autism:severely-autistic_vs_non-sibling-control_DOWN	NA	1683	1679	218538	1535
bsdb:9/1/1_Breast-carcinoma:Breast-Cancer_vs_Control_UP	NA	1445	219301	231049	28901	1771	1766
bsdb:9/1/2_Breast-carcinoma:Breast-Cancer_vs_Control_DOWN	NA	40216	562	329	33917
bsdb:10/2/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1681	215580	2702
bsdb:11/1/1_Cervical-glandular-intraepithelial-neoplasia:HIV-patients-with-lesion-at-12-months_vs_HIV-pateints-with-normal-tissue-at-6-months_DOWN	NA	2702
bsdb:12/1/1_Human-papilloma-virus-infection:HPV-persistent_vs_HPV-clearance_UP	NA	387661
bsdb:12/2/1_Human-papilloma-virus-infection:HPV-clearance_vs_HPV-negative_UP	NA	2702	2130
bsdb:12/3/1_Human-papilloma-virus-infection:HPV-negative_vs_HPV-presistent-and-clearance_UP	NA	47770
bsdb:12/4/1_Human-papilloma-virus-infection:HPV-clearance_vs_HPV-presistent-and-negative_UP	NA	39485
bsdb:13/1/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_UP	NA	47770	817	1311	827
bsdb:13/1/2_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_DOWN	NA	38293	109790	82135
bsdb:13/2/1_Cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_UP	NA	1311	817	316	1261
bsdb:13/2/2_Cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_DOWN	NA	1584
bsdb:14/1/1_Halitosis:Oral-Halitosis_vs_Control_UP	NA	739
bsdb:14/1/2_Halitosis:Oral-Halitosis_vs_Control_DOWN	NA	729	2047
bsdb:16/2/2_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	152490
bsdb:17/1/1_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	33038	1522
bsdb:17/1/2_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	39485	438033	39491
bsdb:17/2/1_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	33038	33039	1522
bsdb:17/2/2_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	290054	42322	39497	39485	438033	39491
bsdb:18/1/1_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	43305	154046	1351	658087	1605	168384	351091	106588	166486	360807	89153	29347	49118
bsdb:18/1/2_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239935	1735
bsdb:18/2/1_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	154046	1351	1352	1605	168384	166486	360807	29347	49118
bsdb:18/2/2_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239935	1735
bsdb:18/3/2_Obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	239935	1535	1735	89152
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	626937	270498	97478	40518	100176
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	204516	536633	1470350	310298	40519	88431	357276	165179	310297	33043
bsdb:24/1/2_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	351
bsdb:26/1/1_Sex-design:female_vs_male_UP	NA	47678
bsdb:26/1/2_Sex-design:female_vs_male_DOWN	NA	310297
bsdb:26/2/2_Obesity:BMI->33-female_vs_male_DOWN	NA	310297
bsdb:31/1/1_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	105841	333367	106588	29347	1512	33038	100884
bsdb:31/1/2_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	28117	39488	40520	116085	39486	88431	39496	853	729	823	360807	1971605
bsdb:31/2/1_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	105841	208479
bsdb:31/2/2_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	39488	116085	410072	39486	88431	853	360807	1971605	40520
bsdb:31/3/1_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	351	100884	88431	84112	106588	29347	1512	33038	1506
bsdb:31/3/2_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	116085	823	39486
bsdb:32/1/1_Anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_UP	NA	2173
bsdb:33/1/1_Obesity:obese_vs_controls_UP	NA	53443	116085	39496	40518	40520
bsdb:33/1/2_Obesity:obese_vs_controls_DOWN	NA	292800	871325	818	418240	208479
bsdb:36/1/1_Obesity:obese-adolescent_vs_control-adult_UP	NA	74426	1747	853
bsdb:36/2/1_Obesity:obese-adult_vs_control-adolescent_UP	NA	1747	853
bsdb:36/2/2_Obesity:obese-adult_vs_control-adolescent_DOWN	NA	47678
bsdb:36/3/1_Obesity:control-adolescent_vs_control-adult_UP	NA	47678
bsdb:36/4/1_Obesity:obese-adolescent_vs_obese-adult_UP	NA	74426	853
bsdb:36/5/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	74426	1747	853	29466
bsdb:36/5/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	47678
bsdb:36/6/1_Obesity:obese-adult_vs_control-adult_UP	NA	1747	853
bsdb:38/1/1_Body-odor-measurement:head-of-teenager_vs_head-of-child_UP	NA	1747
bsdb:38/1/2_Body-odor-measurement:head-of-teenager_vs_head-of-child_DOWN	NA	76773	1282	1290
bsdb:38/2/1_Body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1747	76773
bsdb:38/2/2_Body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1290
bsdb:38/3/1_Body-odor-measurement:teen-underarm_vs_child-underarm_UP	NA	76773	1282
bsdb:38/3/2_Body-odor-measurement:teen-underarm_vs_child-underarm_DOWN	NA	1290
bsdb:39/1/1_Body-odor-measurement:youth-underarm-after-exercise_vs_youth-underarm-before_UP	NA	1282
bsdb:39/2/1_Body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	33011	108981
bsdb:40/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	28026	1679	1680	821	28116	820
bsdb:40/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	33043
bsdb:41/1/1_Psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	1579	197162	95486	885581	927	86304	622488	2039	36855	33959	2247	1598	133539	56426	529	1613	1624	1596	1689
bsdb:41/1/2_Psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	337090	370405	42353	1231	187878	264691	628	115778
bsdb:43/1/1_Behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	729
bsdb:43/1/2_Behcet's-syndrome:behcet's-disease_vs_controls_DOWN	NA	55565	671218	199	76123	979627	1382	104608	60133	2053611	102148	1926307
bsdb:43/2/1_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	41976
bsdb:43/2/2_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_DOWN	NA	305719	1969407
bsdb:44/1/1_Obesity:pediatric-obese_vs_controls_UP	NA	853
bsdb:44/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	821	46506
bsdb:46/1/1_Obesity:pediatric-obese_vs_controls_DOWN	NA	239935	853	4935	1853550
bsdb:46/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	239935	853	4935	1983405	1853550
bsdb:46/2/1_Obesity:pediatric-obese_vs_controls_UP	NA	39491	5476	4932
bsdb:51/1/2_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	33038
bsdb:51/2/2_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	290054
bsdb:59/1/2_Titanium-dioxide-nanoparticle:pregnant-rats-exposed-to-titanium-dioxide-nanoparticles_vs_control-pregnant-rats-at-gestational-day-10_DOWN	NA	234266
bsdb:61/2/1_Obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-6-month_UP	NA	1498	1686
bsdb:61/4/1_Obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-6-months_UP	NA	1498
bsdb:62/1/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	1671661	1940338	290054	1946507	2613924	573	357276	1806836
bsdb:62/1/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1235800	3068309
bsdb:62/2/2_Cognitive-impairment:Mild-Cognitive-Impairment-PD_vs_Cognitively-Unimpaired-PD-(PD-NC)_DOWN	NA	239935
bsdb:62/3/1_Parkinson's-disease:Mild-Cognitive-Impairment--PD-(PD-MCI)_vs_Control-Subjects_UP	NA	1671661	1940338	290054	1946507	2613924	573	357276	1806836
bsdb:62/3/2_Parkinson's-disease:Mild-Cognitive-Impairment--PD-(PD-MCI)_vs_Control-Subjects_DOWN	NA	1235800	3068309
bsdb:62/4/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	1671661
bsdb:62/4/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	3068309	1235800
bsdb:62/6/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	1946507	1806836	1671661	290054
bsdb:62/6/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	3068309	1235800
bsdb:63/1/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-7-days-of-delivery_DOWN	NA	1596
bsdb:63/3/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-6-months-of-delivery_DOWN	NA	1598
bsdb:64/1/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_UP	NA	69823	1302
bsdb:64/1/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	1019	2718	194702	43768	840	484	1924944	135083
bsdb:64/2/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative-periodontitis_UP	NA	28112
bsdb:64/2/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative-periodontitis_DOWN	NA	1018	194702	43768	840	484
bsdb:64/3/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-positive-periodontitis_UP	NA	1019
bsdb:64/4/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	143361	28124	837	28112	58231
bsdb:64/4/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	729	495	2047
bsdb:64/5/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_UP	NA	28131	158
bsdb:64/5/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_DOWN	NA	1655	1302	68892
bsdb:65/1/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	28037	851	29466	39778	539
bsdb:65/1/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	143361	837	28112
bsdb:66/1/2_Neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_DOWN	NA	1690
bsdb:66/2/1_Neonatal-jaundice:infants-with-jaundice_vs_control_UP	NA	1502
bsdb:66/2/2_Neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	43675
bsdb:68/1/1_Obesity:obese_vs_normal-weight_UP	NA	31971	28116
bsdb:68/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	853
bsdb:68/2/1_Obesity:overweight_vs_normal-weight_UP	NA	853
bsdb:68/3/1_Obesity:obese-men_vs_normal-weight-men_UP	NA	823
bsdb:68/4/2_Obesity:overweight-men_vs_normal-weight-men_DOWN	NA	33038
bsdb:68/5/1_Obesity:obese-women_vs_normal-weight-women_UP	NA	33038
bsdb:68/5/2_Obesity:obese-women_vs_normal-weight-women_DOWN	NA	1898207
bsdb:68/6/1_Obesity:overweight-women_vs_normal-weight-women_UP	NA	33038
bsdb:70/1/1_Obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	28111	85831	28116	165179
bsdb:70/1/2_Obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	310297	363265	165179
bsdb:70/2/1_Obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/1_Obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/2_Obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_DOWN	NA	310297
bsdb:74/1/1_Obesity:obese_vs_non-obese_UP	NA	39486	100176	1512
bsdb:74/1/2_Obesity:obese_vs_non-obese_DOWN	NA	76122	817	329854	28116	46506	820	28134	28118	823	310297	839
bsdb:74/2/1_Obesity:obese_vs_Nonobese-microbiota-cluster_UP	NA	1512	36835	39488
bsdb:74/2/2_Obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	817	329854	28118	119853
bsdb:74/3/1_Obesity:high-BMI_vs_low-BMI_UP	NA	39486	1736	548	573	33038	100176	166486	36835
bsdb:74/3/2_Obesity:high-BMI_vs_low-BMI_DOWN	NA	511	817	329854	820	100884	853	28134	28118	823	310297	821	839
bsdb:74/4/1_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	29370	100176	166486	214851
bsdb:74/4/2_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	329854	28118	823	310297	821
bsdb:78/1/2_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	31971	239935	248039
bsdb:79/1/1_Obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	469593	411489	40520	88431
bsdb:79/2/1_Obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	53443	556261	411486	1352	1736	84030	1512	100884
bsdb:81/1/1_Obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_UP	NA	562	573	1304	39777	29466	1343	1318	39778	1313	1308	113107	239935	1502	68892	1302	1328	46228	328814	28118	1689	1351	187326	169435
bsdb:81/1/2_Obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_DOWN	NA	853
bsdb:81/2/1_Obesity:one-year-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_UP	NA	573	562	1304	39777	29466	1343	1318	39778	1308	113107	68892	328814	46124	1660
bsdb:82/1/1_Obesity:before-surgery_vs_lean-controls_UP	NA	853
bsdb:82/1/2_Obesity:before-surgery_vs_lean-controls_DOWN	NA	29348	159	860
bsdb:83/1/1_Obesity:before-surgery_vs_after-surgery_UP	NA	40214	105841	159	410072	853	833	860	1579	173	1598	1768	53461	300	1282	500	160	29348
bsdb:83/1/2_Obesity:before-surgery_vs_after-surgery_DOWN	NA	69218	28901	621	39778	29466
bsdb:84/1/1_Obesity:after-surgery_vs_lean-controls_UP	NA	69218	29466	621
bsdb:84/1/2_Obesity:after-surgery_vs_lean-controls_DOWN	NA	29348	159	1598	105841	860	500	1282	833
bsdb:88/1/2_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	729
bsdb:89/1/2_Crohn's-disease:CD-patients_vs_Healthy-controls_DOWN	NA	871665	166486	33039	460384
bsdb:91/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	654	1390	1402	853	821	39491
bsdb:91/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1747	285
bsdb:94/1/1_Obesity:3-months_vs_baseline-participants_UP	NA	13335	74426	487175	166486	360807	214851	469610
bsdb:94/1/2_Obesity:3-months_vs_baseline-participants_DOWN	NA	81028	984	214856	156974	49338	1564	69823	169435	253239	351091	106588	61171	1398	1351	1352	61624	1496	333367	168384	443143	562	316	1902	84110	84112	239935	81462	651822
bsdb:94/2/1_Obesity:6-months_vs_3-months-participants_UP	NA	214856	156974	333367	84030	876	562	84112	471189	81462
bsdb:94/2/2_Obesity:6-months_vs_3-months-participants_DOWN	NA	13335	1358	349221	487175	360807	1308	29466	469610
bsdb:94/3/1_Obesity:24-months_vs_6-months-participants_UP	NA	984
bsdb:94/3/2_Obesity:24-months_vs_6-months-participants_DOWN	NA	239935	562	74426
bsdb:96/1/1_Obesity:obese_vs_controls_UP	NA	187327	1379	46124	573	1382	341694	821	301302	43675	52773	649756
bsdb:96/1/2_Obesity:obese_vs_controls_DOWN	NA	358743	853	61171	1547	39484	290055
bsdb:97/1/1_Obesity:obese-patients-prior-to-Sleeve-gastrectomy-SG0_vs_healthy-controls_UP	NA	850
bsdb:97/3/1_Obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	1308	214856
bsdb:97/4/2_Obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1308
bsdb:98/1/1_Chronic-kidney-disease:CKD_vs_controls_UP	NA	351	631
bsdb:98/1/2_Chronic-kidney-disease:CKD_vs_controls_DOWN	NA	378494
bsdb:99/1/1_Obesity:obese_vs_controls_UP	NA	40520	74426	410072	39486	88431	861	856	907	33038	33039	39488
bsdb:99/1/2_Obesity:obese_vs_controls_DOWN	NA	28116	371601	820	818	329854	328814	239935	28117	28118	28111	573	571	729	853
bsdb:101/1/2_Obesity:obese_vs_lean-controls_DOWN	NA	2173	28025	1597	1590
bsdb:108/1/1_Anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	817	1590	1532	1535
bsdb:110/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	562
bsdb:110/1/2_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1532
bsdb:111/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39485
bsdb:113/1/1_Unipolar-depression:MDD_vs_controls_DOWN	NA	1603
bsdb:115/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	562	907	351091	1680	28132	1689
bsdb:115/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	729
bsdb:115/2/1_Bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	290053
bsdb:116/1/2_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	1532	39491
bsdb:117/1/1_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	257758
bsdb:117/1/2_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	28132	39778
bsdb:117/2/1_Pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	257758
bsdb:117/2/2_Pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	28132	39778
bsdb:118/1/1_Cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	1603	1898207
bsdb:119/1/2_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_DOWN	NA	47678
bsdb:120/1/2_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	39491
bsdb:120/2/2_Physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	39491
bsdb:121/1/1_Gingivitis:gingivitis_vs_healthy-controls_UP	NA	241556	28124	837	28131
bsdb:122/1/1_Breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	31998
bsdb:122/1/2_Breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13690	48935	257758
bsdb:124/1/1_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_UP	NA	418240	550
bsdb:124/1/2_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1680	40519	47678	562
bsdb:124/2/2_Diet:body-builders-(high-protein)_vs_control_DOWN	NA	418240	39488	46506	40519	1679	562	1599
bsdb:124/3/2_Diet:distance-runners-(high-carb)_vs_control_DOWN	NA	550	1583	1522	47678	39488	418240
bsdb:129/1/1_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_UP	NA	351
bsdb:131/4/1_Diet:Cara-Cara_vs_controls-at-time-7_UP	NA	31971
bsdb:131/6/1_Diet:Cara-Cara_vs_Bahia-at-time-7_UP	NA	31971
bsdb:134/1/1_Diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	39488
bsdb:134/2/1_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	39488	1579	562
bsdb:134/2/2_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	2173
bsdb:136/2/1_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84112	404403	1358	1679	88431	1680	74426
bsdb:136/2/2_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	626929	28111	39485	626940	310297	301301	572010	46228	39492
bsdb:139/1/2_Head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	327575	425941	69823
bsdb:139/2/1_Squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	502	1305
bsdb:139/3/1_Squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	544580	419208
bsdb:139/4/2_Squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_DOWN	NA	490	33033
bsdb:141/1/1_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	309120	33036	28125	386414
bsdb:141/1/2_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1633
bsdb:145/1/1_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	28132	1017	28037	1018
bsdb:145/1/2_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	40542	467210
bsdb:149/1/2_Obesity:Obese-children_vs_Normal-weight-children_DOWN	NA	649756	674529	28116	291644	371601	35833	410072	39486	358743	1308	29466	658087	457412
bsdb:150/1/1_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	351
bsdb:150/2/1_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	351
bsdb:151/1/1_Breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_UP	NA	562	624	584	621	666	564	623	470	40214	587	97478	281920	851	545	901	1353	28901	552	63612	40216	856	187327	419005	630	33037	24
bsdb:151/1/2_Breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_DOWN	NA	39485	208962	199	360807	29459	1633
bsdb:152/2/1_Cervical-cancer:cervical-cancer-patients_vs_healthy-controls_UP	NA	46506	562	823	310297	360807
bsdb:155/1/1_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	28112	181487
bsdb:155/1/2_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	61592	425941	1313	617123	1501329	102148	484	490
bsdb:155/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	425941	28091	69710
bsdb:155/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	732
bsdb:156/1/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	39491
bsdb:156/2/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	39491
bsdb:158/2/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	310297	821
bsdb:158/2/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	1898207
bsdb:159/2/2_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	1077464
bsdb:161/1/2_Lung-cancer:NSCLC_vs_Healthy-controls_DOWN	NA	28132
bsdb:166/1/1_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	33038	33039	1522
bsdb:166/1/2_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	39488	290054	39491
bsdb:167/1/1_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	739	1872471	419015	156456	28113	824	205	39950	539	562	143361	860	137732	727	104608	495	1107316	1969407	33033	1924944	2053611	69823	76860
bsdb:167/1/2_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_DOWN	NA	52769	46124	425941	28132	157692	52768
bsdb:167/2/1_Squamous-cell-carcinoma:Stage-1_vs_healthy-controls_UP	NA	205	143361	860	137732	727	1107316	33033	1924944	76860
bsdb:167/2/2_Squamous-cell-carcinoma:Stage-1_vs_healthy-controls_DOWN	NA	729	1583331	28132	1660	29466
bsdb:167/3/1_Squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	739	156456	824	205	143361	860	137732	727	33033	1924944	69823	76860
bsdb:167/3/2_Squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_DOWN	NA	729	1583331	28132	1660	28037	29466	1226342
bsdb:169/1/1_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	327575
bsdb:169/1/2_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	187326	142586	61235
bsdb:169/2/1_Gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_UP	NA	187326	69823	439703	35518
bsdb:169/2/2_Gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	108980	1624
bsdb:169/3/1_Gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	84135	1019	729	479370
bsdb:169/4/1_Gastric-cancer:yellow-thin-coating-GC-patient_vs_other-coatings_DOWN	NA	1052096
bsdb:170/4/2_Lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_DOWN	NA	1898207
bsdb:170/5/2_Lung-cancer:contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_vs_control-group-with-no-antibiotics-(No)_DOWN	NA	77133	1898207
bsdb:171/1/1_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	495	837	1660	1318	1305	1306
bsdb:171/1/2_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	55565	1583331	1924944	28132	2047	102148
bsdb:171/2/1_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_UP	NA	739	837	1318	1305
bsdb:171/2/2_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_DOWN	NA	28132	2047	113107
bsdb:171/3/1_Esophageal-cancer:esophageal-cancer-patients_vs_controls_UP	NA	739	157688	104608	187326	837	1306
bsdb:171/3/2_Esophageal-cancer:esophageal-cancer-patients_vs_controls_DOWN	NA	28132	2047	113107
bsdb:171/4/1_Colorectal-cancer:colorectal-cancer-patients_vs_controls_UP	NA	187326	237576	837	59823	1660	68251	1318
bsdb:171/4/2_Colorectal-cancer:colorectal-cancer-patients_vs_controls_DOWN	NA	1583331	28132	59823
bsdb:171/5/1_Gastric-cancer:gastric-cancer-patients_vs_controls_UP	NA	860	84135	729	837
bsdb:171/5/2_Gastric-cancer:gastric-cancer-patients_vs_controls_DOWN	NA	1924944
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	55565	151416	80866	43675	39777
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	1962306	425941
bsdb:174/1/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	28135	28129	470	287
bsdb:174/1/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	210	615	1580	1358
bsdb:174/2/1_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_UP	NA	615	210	425941	56	55565	1655
bsdb:174/2/2_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_DOWN	NA	28131	287
bsdb:174/3/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	59823
bsdb:180/1/1_Gastric-carcinoma:gastric-carcinoma_vs_chronic-gastritis_UP	NA	134375	1871047	1896336	1506	1871046	306	1831
bsdb:180/1/2_Gastric-carcinoma:gastric-carcinoma_vs_chronic-gastritis_DOWN	NA	218	192066	59823	1306	1966354
bsdb:182/1/1_Acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_UP	NA	84135	29466	484
bsdb:182/1/2_Acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_DOWN	NA	1318	470565
bsdb:183/1/1_Crohn's-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_UP	NA	33039
bsdb:183/1/2_Crohn's-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_DOWN	NA	550	853
bsdb:186/2/1_Smoking-behavior:Smoke-exposed-group-intraperitoneally-injected-with-carcinogen,-AOM-(AOM-+-Smoking)_vs_Smoke-free-control-group-intraperitoneally-injected-with-carcinogen-azoxymethane-(AOM)-(10-mg/kg)_UP	NA	1428	492670	35760	84112	562	1841863	471189	1335613	2530390	1871022	29388
bsdb:186/2/2_Smoking-behavior:Smoke-exposed-group-intraperitoneally-injected-with-carcinogen,-AOM-(AOM-+-Smoking)_vs_Smoke-free-control-group-intraperitoneally-injected-with-carcinogen-azoxymethane-(AOM)-(10-mg/kg)_DOWN	NA	246787	2109688	2109692	1598	823	2025876	357276	821	1307
bsdb:188/1/1_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	257758	28130	2702
bsdb:188/1/2_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_DOWN	NA	47770
bsdb:189/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	1506
bsdb:189/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	1898207	1940338
bsdb:191/1/1_Equol:equol-producers_vs_equol-non-producers_UP	NA	394340	572010
bsdb:194/1/1_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	34062	13690	333965	28090	330920
bsdb:194/1/2_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	1364
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	39485	39491
bsdb:202/2/1_Autism:children-with-autism-non-mental-regression-(ANMR)_vs_healthy-controls_UP	NA	208479
bsdb:202/3/1_Autism:children-with-autism-mental-regression-(AMR)_vs_healthy-controls_UP	NA	208479
bsdb:204/1/1_Premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1596	33959	1679	1685	1579	47770	147802	305
bsdb:205/1/1_Human-papilloma-virus-infection:HPV-positive-women_vs_HPV-negative-women_UP	NA	2702	1596
bsdb:206/1/1_Gastric-cancer:patients-diagnosed-with-gastric-cancer_vs_patients-diagnosed-with-gastritis_UP	NA	179628	285729	851	1596	1598	187326	28131	28135	1302	1318
bsdb:210/1/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	59620
bsdb:212/1/1_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	31971	820
bsdb:212/1/2_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	853
bsdb:212/2/1_Diet:Higher-fiber-intake-from-FRUITS/-VEGETABLES_vs_low-fiber-intake-from-FRUITS/-VEGETABLES_DOWN	NA	820	40518
bsdb:212/3/1_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_UP	NA	853
bsdb:212/3/2_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_DOWN	NA	31971
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239935	626929	28141	853	745368	46503	310297	28126	33038
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	817	1681	1679	1735	1304
bsdb:216/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	47678	817	28116	1686	1679	1502	821	1681	1596	1598
bsdb:217/1/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	40518	29361	46228	1535	29343
bsdb:217/1/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	817	28116	310297	46506	820	821	76122
bsdb:217/2/1_Age:infant-at-18-months_vs_infant-at-6-months_UP	NA	1532
bsdb:217/3/1_Age:infant-at-18-months_vs_infant-at-6-months_UP	NA	45851	100884	140626	33025	40518	40545	1512	220137
bsdb:217/3/2_Age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1590
bsdb:217/4/1_Lactobacillus-rhamnosus-GG:children-supplemented-with-LGG-at-18-months_vs_placebo-group-at-18-months_UP	NA	105841	39496
bsdb:217/4/2_Lactobacillus-rhamnosus-GG:children-supplemented-with-LGG-at-18-months_vs_placebo-group-at-18-months_DOWN	NA	1496
bsdb:218/1/2_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	39496
bsdb:218/3/1_Hepatocellular-carcinoma:non-HBV-non-HCV-patients_vs_HBV-related-HCC-patients_DOWN	NA	39496
bsdb:219/1/1_Diet:lower-fiber-(cracker),-at-baseline_vs_higher-fiber-(almonds)---at-baseline_UP	NA	817
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	1468449	86664	333367	44009	536633
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	1559	1260	729	386414	373040	1537
bsdb:222/1/1_Gastric-cancer:high-gastric-cancer-risk-patients-(Tuquerres-residents)_vs_low-gastric-cancer-risk-patients-(Tumaco-residents)_UP	NA	157687	1926307
bsdb:222/1/2_Gastric-cancer:high-gastric-cancer-risk-patients-(Tuquerres-residents)_vs_low-gastric-cancer-risk-patients-(Tumaco-residents)_DOWN	NA	29317	1017	239	484	192066	1924944	28135	1885016	29387	1303	1310087
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	33038	1343
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	821	165179
bsdb:223/2/1_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_UP	NA	1547
bsdb:223/2/2_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_DOWN	NA	165179
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	33038
bsdb:223/5/1_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_UP	NA	817	562	33038	1308
bsdb:224/1/1_Diet:barley-(WGB)_vs_baseline_UP	NA	418240	301302	166486	39491
bsdb:224/1/2_Diet:barley-(WGB)_vs_baseline_DOWN	NA	28118
bsdb:227/4/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1898207
bsdb:228/1/1_Diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	853
bsdb:228/2/1_Diet:day-3-of-INULIN-spike-in_vs_day-6-of-INULIN-spike-in_DOWN	NA	820	853
bsdb:234/1/1_Atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_UP	NA	1280
bsdb:234/1/2_Atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	36773	1747	1981334	1591	1909303	29387
bsdb:234/2/1_Psoriasis:adult-with-psoriasis_vs_healthy-control_UP	NA	1872515	161879	146827	1981334
bsdb:234/2/2_Psoriasis:adult-with-psoriasis_vs_healthy-control_DOWN	NA	36773	1591	1909303
bsdb:234/3/1_Atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_UP	NA	1981334	376	1872515	34073	1591	1280
bsdb:234/4/1_Atopic-eczema:adults-with-psoriasis_vs_healthy-control_UP	NA	1981334	376	1720	161879
bsdb:235/1/1_Food-allergy:child-with-food-allergy_vs_healthy-control_UP	NA	1971605	351091
bsdb:235/1/2_Food-allergy:child-with-food-allergy_vs_healthy-control_DOWN	NA	1955243	729
bsdb:235/2/1_Food-allergy:child-with-food-allergy_vs_healthy-sibling_UP	NA	351091	1971605
bsdb:235/2/2_Food-allergy:child-with-food-allergy_vs_healthy-sibling_DOWN	NA	729	1955243	28117	1872444
bsdb:235/3/1_Food-allergy:healthy-sibling_vs_healthy-control_UP	NA	351091	1971605	28117	1872444
bsdb:235/3/2_Food-allergy:healthy-sibling_vs_healthy-control_DOWN	NA	1955243	729
bsdb:235/4/1_Age:7-18-years_vs_<7-years_UP	NA	351091
bsdb:237/1/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	1940338
bsdb:241/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	29466	39778	137838
bsdb:241/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	74426	39486	1681
bsdb:242/3/1_Iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	351
bsdb:243/1/2_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12917	1833
bsdb:243/2/1_Gastric-cancer:current-H.pylori-infection-patients_vs_past-H.pylori-infection_UP	NA	820	165179
bsdb:243/3/1_Gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	28111	817	820	310298
bsdb:243/4/1_Gastric-cancer:gastritis-cases_vs_normal_UP	NA	562	877420	37628	2485925	3023528	2807717
bsdb:243/5/1_Gastric-cancer:subjects-with-metaplasia_vs_normal_UP	NA	290054	1898207
bsdb:243/6/2_Gastric-cancer:subjects-with-metaplasia_vs_subjects-with-gastritis_DOWN	NA	1898207
bsdb:244/1/1_Age:18-62-years_vs_2-12-years_UP	NA	1720	1747	1282
bsdb:244/1/2_Age:18-62-years_vs_2-12-years_DOWN	NA	1306
bsdb:244/4/1_Age:18-62-years_vs_2-12-years_UP	NA	1747	1282	147802
bsdb:244/5/1_Atopic-eczema:lesional-skin-in-young-children_vs_non-lesional-skin-in-young-children_UP	NA	1747	38303	29388	29380	28037	1303	1313	1305	45634
bsdb:244/6/1_Atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1280
bsdb:244/7/1_Age:18-62-years_vs_2-12-years_UP	NA	1747	147802	1282
bsdb:244/7/2_Age:18-62-years_vs_2-12-years_DOWN	NA	45634	43675
bsdb:245/1/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	53254	562	287	33038	2212467
bsdb:245/1/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	638849	1680	360807	328814	328813	310297
bsdb:245/2/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	39488	42322
bsdb:246/2/1_Asthma:maternal-asthma_vs_no-asthma_UP	NA	817
bsdb:246/2/2_Asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1506
bsdb:248/1/1_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	351
bsdb:248/2/2_Human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	76761	351
bsdb:249/2/2_Hepatitis,-Alcoholic:HDC_vs_NAC_DOWN	NA	351
bsdb:249/3/2_Hepatitis,-Alcoholic:MAH_vs_NAC_DOWN	NA	351
bsdb:250/1/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	729	43675	114702	84135	237576	28129	1379	860	425941	1924944
bsdb:250/2/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	729	114702	84135	237576	425941
bsdb:250/3/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_UP	NA	729	84135
bsdb:250/4/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_DOWN	NA	43675
bsdb:252/1/1_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_UP	NA	1940338
bsdb:255/1/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	351
bsdb:255/2/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	147802
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	727	1261	1328
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	1598
bsdb:256/1/1_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	239935	817
bsdb:256/1/2_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1396	165179
bsdb:256/2/1_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	351	1396	28132	1328
bsdb:256/2/2_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	210
bsdb:256/3/1_Gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	239935	1747	28132	1328
bsdb:256/3/2_Gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	351	820	210	165179
bsdb:256/4/1_Gastric-cancer:early-stage-tumor_vs_early-stage-normal_UP	NA	1747	1328
bsdb:256/4/2_Gastric-cancer:early-stage-tumor_vs_early-stage-normal_DOWN	NA	165179	172044
bsdb:256/5/1_Gastric-cancer:early-stage-peritumor_vs_early-stage-normal_DOWN	NA	172044
bsdb:256/6/1_Gastric-cancer:late-stage-tumor_vs_late-stage-normal_UP	NA	1747	1328
bsdb:256/8/1_Gastric-cancer:late-stage-peritumor_vs_late-stage-normal_DOWN	NA	165179
bsdb:256/11/2_Gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	351
bsdb:259/1/1_Atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/1_Atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/2_Atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:260/1/1_Food-allergy:Allergic-Estonian-children._vs_Nonallergic--Estonian-children._UP	NA	1280
bsdb:260/2/1_Food-allergy:Allergic-Swedish-children_vs_Non-allergic-Swedish-children._UP	NA	1280
bsdb:261/1/1_Chronic-pancreatitis:autoimmune-pancreatitis-type-1_vs_chronic-pancreatitis_DOWN	NA	28116	205328	460384	113107	1302	160404
bsdb:262/7/1_Atopic-asthma:atopic-asthma-subjects_vs_healthy-controls_UP	NA	1282
bsdb:264/1/1_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	1872515	72409	309120	2023260	1258	1971214	1261	59823	2776143
bsdb:264/1/2_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	1879286	147802
bsdb:265/1/1_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	43675	39778	1872515
bsdb:265/3/1_Human-papilloma-virus-infection:HPV+-at-two-months_vs_HPV--at-two-months_DOWN	NA	39778
bsdb:266/1/1_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_UP	NA	573	28128
bsdb:267/1/1_Atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	76122	147802	28449	165179	117207	59892	39778
bsdb:267/1/2_Atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	71999	57037
bsdb:267/2/1_Atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	739	727	28132	425941	117207	59892	39778
bsdb:267/2/2_Atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	57037
bsdb:267/3/1_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	28449	28131
bsdb:267/3/2_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	739	817	1018	996	727	729	57037	165179	425941	117207	59892	33038
bsdb:267/4/2_Atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	351
bsdb:268/1/1_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	2702	33959	419005	187101
bsdb:269/1/1_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	820	817
bsdb:271/1/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	853	39488	253239	44749
bsdb:271/1/2_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	1659	1655	2047	43675	29361	1335
bsdb:271/3/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	853
bsdb:271/4/1_Acute-lymphoblastic-leukemia:males_vs_female_UP	NA	853
bsdb:271/5/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	39488
bsdb:271/6/1_Acute-lymphoblastic-leukemia:Age-less-than-65-years-old_vs_Age-greater-than-65-years-old_UP	NA	39488
bsdb:273/1/1_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	853
bsdb:273/1/2_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	134375	358	293
bsdb:274/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	40543
bsdb:274/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	33032	938288	851	1596	2052	1465756	1328
bsdb:274/2/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	82135	502393	2052	40543
bsdb:274/2/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1287640	827	1260	851	47770	1596	755172	507750	1465756	1328
bsdb:274/3/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	82135	28127	419005	40543	1311
bsdb:274/3/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	33032	1287640	308994	938288	1260	1596	755172	507750	1465756	33031	28125	28128	28130
bsdb:274/4/1_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_UP	NA	40543
bsdb:274/4/2_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	33032	308994	938288	851	47770	1596	755172	507750	1465756	28125	28128	1328	29318
bsdb:274/5/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1261
bsdb:274/5/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1287640	386414	1465756	28125
bsdb:274/6/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	33032	502393	28127	1596	147802	2052	1261	419005	28130	40543	29318
bsdb:274/6/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	47770	755172
bsdb:274/7/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	147802	419005	40543
bsdb:274/7/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	59505	33032	1287640	827	53374	46507	938288	28127	386414	755172	507750	1465756	33031	28125
bsdb:274/8/1_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	47770	1465756	28125
bsdb:274/9/1_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_UP	NA	851	2098	2052	419005	28130	40543	1311	187328
bsdb:274/9/2_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_DOWN	NA	1596
bsdb:274/10/1_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	82135	2052	40543	1328	187328
bsdb:274/10/2_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	33037	28127	1596
bsdb:276/2/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	28141
bsdb:276/2/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	39488
bsdb:276/3/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	4091
bsdb:276/4/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-relatives-control_UP	NA	287	1535
bsdb:280/1/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	1261	33036	40543
bsdb:280/1/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_DOWN	NA	109790	181675
bsdb:281/1/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_UP	NA	51515
bsdb:283/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2702	1872650	87541	1258	1633
bsdb:283/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	82135	109790	47770
bsdb:284/2/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1655	200	44737	1624	1613	28037	1309	1310	56774
bsdb:284/2/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1151604	45243	726	43995	742463	936567	239138	28131	28132	425941	242668	157692
bsdb:284/4/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1309
bsdb:285/1/1_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	165179
bsdb:285/1/2_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	165179	1261
bsdb:285/3/1_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	239935	47678	28116	33035	853	729	823	310297	165179	363265	39778	33038
bsdb:285/3/2_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	165179	1623	823	820	52226	1261	239935	28111	853	817	387090	28116
bsdb:286/1/1_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_UP	NA	165179
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	328814	39488	39496	1852369	204516
bsdb:286/2/1_Graves-ophthalmopathy:graves-orbitopathy_vs_healthy-controls_UP	NA	165179
bsdb:287/1/1_Human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_UP	NA	87541	33034	1681	1679	1322	449520	827	191610	2702	242750	405	406	485	54005	33030	501496	28132	28137	52773	1660	68569	160	187328
bsdb:287/1/2_Human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	185294	147802
bsdb:287/2/1_Human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_UP	NA	419005	29524	33033	487173	33034	54005	1496	84136	250	33043
bsdb:287/2/2_Human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	544581	1381	288965
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	853
bsdb:289/1/1_Health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	1898207
bsdb:290/2/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	39777	39778	29317	55565	187326	1926307
bsdb:290/2/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1613	230143
bsdb:290/3/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	113107	1318	39777	39778	55565	1379	29391	84135
bsdb:290/3/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1280	29380	1282	1292	230143	1351
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	204	1926307	582
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	1872444	1596
bsdb:293/4/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	134821
bsdb:293/4/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1852374	287
bsdb:293/5/1_Human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_UP	NA	76122	28133	28136	218538
bsdb:293/6/1_Human-papilloma-virus-infection:without-any-HPV-type-cleared_vs_with-any-HPV-type-cleared-in-a-year_UP	NA	502393	419005	1391654	1763509
bsdb:293/7/1_Human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_UP	NA	386414	420324	218538	410072	1182571	1297424
bsdb:293/7/2_Human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_DOWN	NA	1584
bsdb:294/1/2_Acute-lymphoblastic-leukemia:post-induction-therapy_vs_baseline_DOWN	NA	1971605
bsdb:294/3/2_Acute-lymphoblastic-leukemia:post-re-induction-therapy_vs_baseline_DOWN	NA	1971605
bsdb:295/1/2_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	351
bsdb:296/1/1_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-control_UP	NA	573	244366	1303	1302	550	1308	1318	1304	1689	546	74426	28037	548	839	589436	1328	28132	1297617	1313	54291	1680	732	61645	907	351091
bsdb:296/1/2_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-control_DOWN	NA	197614	66219	1561	169679	43305	1496	185008	246787	36745	1869337	28116	1679721	818	823	39485	47678	1686	1520	1505	1491	649756	158847	1492	630129	28026	856
bsdb:296/2/1_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-controls_UP	NA	546	550	548	573	244366	54291	1302	1303	1313	1304	28037
bsdb:296/2/2_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-controls_DOWN	NA	649756	84030	1492
bsdb:299/1/1_Acute-lymphoblastic-leukemia:induction-chemotherapy_vs_baseline_UP	NA	35783
bsdb:301/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2776143
bsdb:302/4/1_Asthma:asthma_vs_healthy-control_UP	NA	28127	218538	2702	208968
bsdb:302/5/1_Asthma:asthma_vs_healthy-control_UP	NA	28127	2702
bsdb:303/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	1898207
bsdb:304/1/1_Antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	105841	109327	40520	33043	39486	84112	853	140626	28052	29370	1590	100176	40518	29361	29343
bsdb:307/1/2_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	214856	328813	28117	328814	487174	1680	28026	35833	1955243	544645	1913682	1506	39486	853	729	261299	39485	28118	1945593	823	487175	360807	40519	1318
bsdb:307/2/1_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	823	35833	360807	28118	1955243	1506	853	40519	328814	487175	1913682	1680	328813	1945593	214856	544645	28117	487174	39485	39486	729	1288121
bsdb:307/3/2_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	35833	1680	261299	28026	292800
bsdb:308/2/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	2030927	2212467
bsdb:308/3/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	2030927	2049048
bsdb:308/3/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	2212467	2030927
bsdb:308/5/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1869337
bsdb:308/5/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1898207
bsdb:309/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	28111	1598	330
bsdb:309/2/1_Cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	351
bsdb:309/3/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	239935	1598
bsdb:309/3/2_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_DOWN	NA	239935	33035	1502	74426	28132	165179	1311
bsdb:314/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	386414	82135
bsdb:314/2/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	386414	2702
bsdb:314/3/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	2702	386414
bsdb:314/4/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	87541
bsdb:317/1/1_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_UP	NA	2485925
bsdb:317/2/1_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_UP	NA	1969407
bsdb:317/2/2_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_DOWN	NA	1904861
bsdb:317/3/2_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	2049031
bsdb:319/1/1_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	214856	2125	28139	1837329
bsdb:319/1/2_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	1970093	1235800	1003360	32025
bsdb:320/1/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/2/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/3/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotic-penicillin_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	28116
bsdb:320/4/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33038
bsdb:320/4/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	817
bsdb:320/5/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-multi-class-antibiotics_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_UP	NA	39778
bsdb:320/6/2_Antimicrobial-agent:infants-to-mothers-exposed-to-cephalosporins_vs_infants-to-mothers-unexposed-to-intrapartum-antibiotic_UP	NA	817
bsdb:324/1/1_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	39488	290054	42322	1970093	1410629
bsdb:324/1/2_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	33038
bsdb:326/1/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_UP	NA	239935	214856	626932	29523	1197717	1352	142586
bsdb:326/1/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_DOWN	NA	1879010	626929	291645	1898207	1506	208479	823
bsdb:326/2/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239935	1879010	47678	291645	371601	1506	142586	1263000	292800	41978
bsdb:326/2/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_DOWN	NA	169435	1879010	823
bsdb:326/3/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders_vs_Non-Responders_DOWN	NA	1283	169292
bsdb:327/3/1_Antimicrobial-agent:infants-received-long-term-(>5days)-antibiotic-treatment---week-1_vs_infants-received-short-term-(<3days)-antibiotic-treatment---week-1_DOWN	NA	1506
bsdb:330/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:330/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	39488	42322	438033	33039
bsdb:332/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	1265
bsdb:332/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	1596
bsdb:335/2/1_Air-pollution:IL-10−/−--mice-fed-mouse-chow-with-PM10_vs_healthy-mice_UP	NA	1409
bsdb:336/3/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_UP	NA	1940338
bsdb:337/1/2_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	239935	137838	227943	1660
bsdb:337/3/2_Antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	423477
bsdb:338/2/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	2382	1502	31971	727	729	387090	165179	43675	39778	36835	33038
bsdb:338/2/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	626932	820	1680	74426	847	304	676517	1302
bsdb:340/1/1_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_UP	NA	239935	53443	469610	1352	658657	469614	562	658089	33038	187326	487175	1311	39778	1522
bsdb:340/1/2_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_DOWN	NA	28026	40520	39486	88431	457422	853	249188	204516	360807	457412	102148	796942	1318	197614	1343	39778	46228	33039
bsdb:344/1/1_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_UP	NA	1945593	68766
bsdb:344/1/2_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_DOWN	NA	351	1306
bsdb:345/1/2_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_DOWN	NA	38286
bsdb:346/1/1_Unipolar-depression:severe-depression_vs_mild-depression_UP	NA	292800	41978	658655
bsdb:346/1/2_Unipolar-depression:severe-depression_vs_mild-depression_DOWN	NA	1288121	1680	847	707003
bsdb:346/2/1_Unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	116085	1328	1512
bsdb:346/3/1_Anxiety-disorder:severe-anxiety_vs_mild-anxiety_UP	NA	1328	658655
bsdb:346/3/2_Anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	39491	28117	1680	116085	39496	301301	360807	41978
bsdb:346/4/1_Anxiety-disorder:moderate-anxiety_vs_mild-anxiety_UP	NA	1358	84112	658081	457421
bsdb:346/5/1_Remission:Yes_vs_No_UP	NA	39491	291645	74426	116085	39486	290054	39496	853	301301	360807	3068309	40519	707003
bsdb:346/5/2_Remission:Yes_vs_No_DOWN	NA	41978	53443	261299	33038
bsdb:346/6/1_Remission:Yes_vs_No_UP	NA	39491	116085	665951	360807	40519	41978	707003
bsdb:346/6/2_Remission:Yes_vs_No_DOWN	NA	291645	53443	658657	1940338	261299	658081	1304
bsdb:347/1/1_Obesity:obese-children_vs_controls_UP	NA	209880	35833	437897	847	823	487175	310297	363265	1512
bsdb:347/1/2_Obesity:obese-children_vs_controls_DOWN	NA	239935	671218	645466	105841	817	28116	818	89014	418240	44008	1547	853	471189	341220	102148	76860	1304	1535	1549	143393
bsdb:348/1/1_Obesity:obese-children_vs_lean-children_UP	NA	817	1591
bsdb:348/1/2_Obesity:obese-children_vs_lean-children_DOWN	NA	41200
bsdb:348/2/1_Obesity:overweight-children_vs_lean-children_UP	NA	817	1591
bsdb:348/3/1_Obesity:obese-children_vs_lean-children_UP	NA	817
bsdb:348/3/2_Obesity:obese-children_vs_lean-children_DOWN	NA	41200
bsdb:348/4/1_Obesity:overweight-children_vs_lean-children_UP	NA	1591
bsdb:349/1/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure_vs_normal_UP	NA	2702	134821	2098
bsdb:349/2/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure_vs_normal_UP	NA	2702	134821
bsdb:349/3/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure-(age-<46)_vs_normal_UP	NA	2702	2098	134821
bsdb:349/4/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure_vs_normal_UP	NA	2702	134821
bsdb:349/5/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-6-months-post-procedure_vs_normal_UP	NA	2702	2098	134821
bsdb:349/6/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-12-months-post-procedure_vs_normal_UP	NA	2702	2098	134821
bsdb:350/1/1_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_UP	NA	1680	853
bsdb:350/2/1_Obesity:Obesity-with-metabolic-syndrome-(OMS)_vs_Normal-weight-(NW)_UP	NA	74426
bsdb:353/1/1_Obesity:obese_vs_non-obese_UP	NA	853
bsdb:354/1/2_Obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	239935
bsdb:355/1/1_Obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_UP	NA	1591
bsdb:355/1/2_Obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_DOWN	NA	821
bsdb:356/1/2_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	1940338
bsdb:356/3/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1945593
bsdb:356/6/1_Air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1872530
bsdb:358/1/1_Cervical-glandular-intraepithelial-neoplasia,Cervical-cancer:CIN2/3-CC_vs_Healthy-controls_UP	NA	43770	1747	225324	851	88164	1599	286638	1270	419005	1313	165096
bsdb:361/3/1_Air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	59823
bsdb:361/4/1_Air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	1872421
bsdb:361/4/2_Air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	194843	2049031
bsdb:364/1/1_Smoking-behavior:smokers_vs_non-smokers_UP	NA	113107	228604	28132	43675	39777
bsdb:365/1/2_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	142586
bsdb:367/1/1_Obesity:obese_vs_normal-weight_UP	NA	1971605	1955243	2049024	2049040
bsdb:367/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	2053619	558
bsdb:368/1/1_Smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	43675	1306	52773	419015	227942	28037	1343	249188	484	29466	34026	554406	29317	1305	495
bsdb:368/1/2_Smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	539	1306	1501332	237576	104608
bsdb:371/2/1_Obesity:obese-and-overweight-subjects_vs_lean-and-anorexic-subjects_DOWN	NA	2173
bsdb:371/3/1_Obesity:obese-subjects_vs_lean-subjects_DOWN	NA	28025
bsdb:371/3/2_Obesity:obese-subjects_vs_lean-subjects_UP	NA	1598
bsdb:371/4/1_Obesity:overweight-subjects_vs_lean-subjects_UP	NA	1598
bsdb:371/5/1_Obesity:obese-subjects-(species-level)_vs_anorexic,-lean,-and-overweight-subjects-(species-level)_DOWN	NA	28025
bsdb:371/6/1_Obesity:obese-and-overweight-subjects_vs_lean-and-anorexic-subjects_UP	NA	1598
bsdb:372/1/2_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	1898207	1506
bsdb:373/1/1_Obesity:overweight-children_vs_normal-weight-children_UP	NA	39491	1681	1335	45851	1268254
bsdb:373/1/2_Obesity:overweight-children_vs_normal-weight-children_DOWN	NA	239935	1288121	649756	246787	28111	28116	818	820	487174	28025	35833	2317	454154	821	1473216	1586779
bsdb:373/2/1_Obesity:Overweight-children_vs_Adults_UP	NA	1680	28026	418240	100886	1898207	1506	88431	410072	2137877	1160721	84112	1335	1268254
bsdb:373/2/2_Obesity:Overweight-children_vs_Adults_DOWN	NA	1473216	33043	165179	40519	39496
bsdb:373/3/1_Obesity:normal-weight-children_vs_Adults_UP	NA	446660	338188	818	1680	28025	28026	418240	100886	88431	1260	261299	2317	310298	204516	1160721	877428	2028282
bsdb:373/3/2_Obesity:normal-weight-children_vs_Adults_DOWN	NA	166486	40519	331630
bsdb:375/1/1_Obesity:obese_vs_normal-weight_UP	NA	1535
bsdb:375/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	562
bsdb:376/2/1_Antimicrobial-agent:patients-that-took-levofloxacin_vs_before-antibiotic-exposure_UP	NA	310297
bsdb:377/1/1_Smoking-behavior:e-cigarette-smokers_vs_non-smokers_DOWN	NA	860	68766	979627	47671	1501329	2049038	59823	1303	1583331
bsdb:377/1/2_Smoking-behavior:e-cigarette-smokers_vs_non-smokers_UP	NA	419015	143361	651822	851	1358	2049034	267212	1969407	33033	28124	281920	310514	28135	59823	671224	135079	84109	29388	39778	152509
bsdb:377/2/1_Smoking-behavior:cigarette-smokers_vs_never-smokers_UP	NA	46125	52769	1017	45243	327575	1019	2718	43997	61592	539	860	137732	726	735	740	979627	47671	1107316	192066	1501329	1898956	2049038	341694	1583331	59823	43675	102148	1303	423477
bsdb:377/2/2_Smoking-behavior:cigarette-smokers_vs_never-smokers_DOWN	NA	114702	419015	895	143361	651822	851	1596	1358	187326	2023260	2049034	1969407	33033	33031	28124	281920	28129	28131	439703	310514	28134	28135	28136	59823	28137	638849	230143	671224	135079	84109	1318	158	51160	166	39777	39778	1926307
bsdb:377/3/1_Smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_UP	NA	1017	45243	1019	2718	43997	61592	539	860	726	740	47671	1107316	192066	2049038	341694	1583331	59823	43675	423477
bsdb:377/3/2_Smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_DOWN	NA	114702	419015	1940337	187326	59823	1318
bsdb:378/1/1_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	59823
bsdb:378/2/2_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	1547	1946507
bsdb:379/1/1_Obesity:non-obese_vs_obese_UP	NA	1679	158787	77635	1613	47493	227945
bsdb:379/2/1_Obesity:obese_vs_non-obese_UP	NA	29317	46124	45634
bsdb:379/2/2_Obesity:obese_vs_non-obese_UP	NA	712149
bsdb:382/1/1_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	87541
bsdb:382/2/1_Chlamydophila-infectious-disease,Human-papilloma-virus-infection:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	813
bsdb:385/1/1_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_UP	NA	490	28037	1303	1313	28124	739
bsdb:385/1/2_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_DOWN	NA	55565	1884818	1382	237576	28129	43675	13690	1328	113107	45634	1318	1305	56774	121428
bsdb:386/1/1_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	208479
bsdb:386/1/2_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_DOWN	NA	39491	239935	1680	1679	28026	40520	74426	410072	2049024	751585	39486	88431	729	39485	437897	158847	491921	301301	166486	360807	40545	46228
bsdb:389/1/2_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	28449
bsdb:389/2/2_Schizophrenia:mania_vs_healthy-controls_DOWN	NA	28449
bsdb:390/1/1_Schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	707003
bsdb:390/1/2_Schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	707003
bsdb:390/2/1_Schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	707003
bsdb:397/1/1_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	1280	146827	172044
bsdb:397/1/2_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	425941	28132	43675
bsdb:399/1/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	68766	740	2044938
bsdb:399/2/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	1898207
bsdb:399/2/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	2137877
bsdb:403/2/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	29466	137838
bsdb:403/2/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1679
bsdb:403/4/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	29466	817
bsdb:403/4/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1681
bsdb:403/6/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	853	1679
bsdb:414/1/1_Epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	39491	216816	1680
bsdb:414/1/2_Epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	562
bsdb:415/4/1_Coinfection,Age:aging-HIV-infected-women-with-coinfections_vs_young-HIV-infected-group-without-coinfection_UP	NA	885	1591	1598	248039	1965233	44273
bsdb:415/4/2_Coinfection,Age:aging-HIV-infected-women-with-coinfections_vs_young-HIV-infected-group-without-coinfection_DOWN	NA	102148	2704657	29466
bsdb:416/1/1_HIV-infection,Antimicrobial-agent:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_UP	NA	371601	562	28118	328812	387661	166486	2585118
bsdb:416/1/2_HIV-infection,Antimicrobial-agent:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_DOWN	NA	729	1735	1318	853	1304	328813	261299	84112	1309	1343
bsdb:424/1/1_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_UP	NA	1898203
bsdb:424/1/2_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_DOWN	NA	1506	2485925	77133
bsdb:424/4/1_Pancreatic-carcinoma:NBO-PC_vs_Healthy-control_DOWN	NA	1970093
bsdb:428/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	357276	821	33038	33039	28116	47678	239935
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1680	39491	40518	28026	853	74426	40520	88431	410072	39486
bsdb:428/2/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	1689	88431	208479	1623	823	1869337	165179	457412	1304	29466	1512
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	28117	1679	28026	74426	410072	39486	39491	853	40518	40520
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	1689	1623	823	1351	208479	1512	29466
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	39491	40518	853	28026	74426	1679	457412	40520	165179	410072	39486	88431	28117	1304	39488
bsdb:428/4/1_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	1680	39486	88431	853	40520	2053618	573	446660	1535	410072	665956	33945	39496	1896336
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	39488	47678	28116	457412	78259	1747	84163	177972	78258	1353	936594	652706	658089	2049041	138595	116085	1383	1280	172042	46125	360807	796942	1282	649756	39490	230143	40545	328813	133926	1869337
bsdb:429/1/1_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_UP	NA	197
bsdb:429/1/2_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_DOWN	NA	1179787	28131	28132	28133	1343	1306
bsdb:430/1/1_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_DOWN	NA	46506	1898203	46503	328813
bsdb:430/1/2_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_UP	NA	74426	626935	582	68892
bsdb:431/2/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_DOWN	NA	1522
bsdb:431/3/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	1522
bsdb:431/5/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_UP	NA	1311
bsdb:431/5/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	38304	1671	169292	33039	28130	755172	1689	1280	53345	1624	309120
bsdb:431/6/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_UP	NA	33039
bsdb:431/6/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_DOWN	NA	6337	206041	1217282
bsdb:431/7/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_UP	NA	311235	206041	1217282
bsdb:431/8/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	46914
bsdb:431/9/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	28132	420645	33031	28130
bsdb:434/2/1_Cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_UP	NA	419005
bsdb:434/3/1_Cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	386414
bsdb:434/4/1_Cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	372463	281920
bsdb:435/1/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_UP	NA	68569	310298	29362
bsdb:435/1/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_DOWN	NA	147802
bsdb:435/2/1_Human-papilloma-virus-infection:HPV+-transient_vs_HPV--controls-and-HPV+-persistent-patients_UP	NA	147802
bsdb:435/3/1_Human-papilloma-virus-infection:HPV+-persistent_vs_HPV+-transient_UP	NA	68569
bsdb:435/3/2_Human-papilloma-virus-infection:HPV+-persistent_vs_HPV+-transient_DOWN	NA	147802
bsdb:435/4/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls_UP	NA	40543	68569
bsdb:435/4/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls_DOWN	NA	147802
bsdb:436/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+/cervical-cancer_vs_healthy-controls_UP	NA	218538	82135	1260	2702	28127	386414
bsdb:437/1/1_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_UP	NA	33036	1393034	813	218538	309120	851	2702	502393	1276	884684	2051	37327	133926	266	33033	363849	54005	33031	1261	419005	28125	28128	28130	28132	131111	102148	114687	316	187328	66851	31281	203908	252598	1392244	76775	5476	114525	4932	114524	931244
bsdb:437/1/2_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_DOWN	NA	1579349	1485682	5478	91626	27978
bsdb:439/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	425254	1492	29363
bsdb:439/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	901	36841	46228
bsdb:440/1/1_Rosacea:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_UP	NA	76122	827	161879	66228	28131
bsdb:440/1/2_Rosacea:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_DOWN	NA	227476	281091	33011	156974	588	38313
bsdb:440/2/1_Rosacea:Participants-with-erythematotelangiectatic-rosacea_vs_Healthy-controls_DOWN	NA	281091	28124	588	207340	38313	33038
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	39488	33039
bsdb:441/2/1_Influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_DOWN	NA	39488	33039	41978
bsdb:441/3/1_COVID-19:COVID-19-patients_vs_H1N1-patients_UP	NA	39488	33038	33039
bsdb:442/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	887091	5599	749840	29918	5480
bsdb:442/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	5551	76775
bsdb:443/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	1532	33035	287
bsdb:443/2/1_Irritable-bowel-syndrome:IBS-C_vs_Health-Control_UP	NA	1532	33035	287
bsdb:443/2/2_Irritable-bowel-syndrome:IBS-C_vs_Health-Control_DOWN	NA	1686
bsdb:443/3/1_Irritable-bowel-syndrome:IBS-D_vs_Health-Control_UP	NA	49118	287
bsdb:443/3/2_Irritable-bowel-syndrome:IBS-D_vs_Health-Control_DOWN	NA	1686
bsdb:443/5/2_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome,-constipation-predominant-(IBS-C)_vs_Irritable-Bowel-Syndrome,-diarrhea-predominant-(IBS-D)_DOWN	NA	49118
bsdb:443/6/1_Irritable-bowel-syndrome:Visible-abdominal-distension_vs_No-Visible-abdominal-distension_UP	NA	1532	49118	287	818
bsdb:443/7/1_Irritable-bowel-syndrome:Abdominal-Bloating_vs_No-Abdominal-Bloating_UP	NA	1532
bsdb:446/1/1_COVID-19:COVID-19-cases_vs_COVID-19-negative-controls_DOWN	NA	38284
bsdb:449/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1852377	2696063	28446	1396	1813611	57706	546	2077147	1898207	2109688	1520	217159	32013	285	61645	881260	69218	550	2027919	158836	208224	2478464	1812935	885040	399742	2596949	1827481	2707174	853	477680	292800	1134687	571	66219	84030	29370	1590	1584	33959	28038	83655	2714951	2681307	1920114	2282309	61646	1907578	2153385	1624	1613	1598	2081964	1421	2100	2067957	189425	1473112	2575375	450367	28101	61647	237609	47885	76760	306	1338689	1611770	1636610	2069256	34038	329	172042	43675	867	52773	1933220	2003121	2219696	1904944	1304	1305	712624	83771	2036206	436515	34073	434009	2126319	55601	33038	114708
bsdb:449/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	203	204	221027	66219
bsdb:452/1/1_Gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	297314
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	877428
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	1506
bsdb:454/1/1_Colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_UP	NA	1940338
bsdb:455/3/1_Gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	713051	56142	712991	713049	712739	51123	43997	51160	143361	651822	28112	53418	712725	712459	714	671227	158	2699746
bsdb:455/3/2_Gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_DOWN	NA	29466	1655	1304	46124	2047	1226342	712124	712118	505	712414	712362	712538	712503	55565	1382
bsdb:455/4/1_Pregnancy:pregnant-women_vs_non-pregnant-women_UP	NA	55565	1872471	76122	45243	651822	2699746	860	157692	157691	104608	187326	56142	837	305719	52227	28129	28132	189723	59823	230143	2053611	69823	28112	158	166	29466	1926307	51123
bsdb:455/4/2_Pregnancy:pregnant-women_vs_non-pregnant-women_DOWN	NA	712187	29391	740	267212	172042	1306	217202
